Skip to main content

Allergy Program News

Experts from CHOP’s Allergy Program are recognized as global leaders in the management of allergic conditions and have helped formulate many of the national guidelines used by physicians around the world.

Contact us

Researchers at Children’s Hospital of Philadelphia Highlight Benefits of Proton Therapy for Pediatric Hodgkin Lymphoma Patients

Oct 8, 2024

A new study from Children’s Hospital of Philadelphia (CHOP) showed promising results for Pediatric Hodgkin Lymphoma (pHL) patients who underwent proton therapy to treat their disease in rare regions located below the diaphragm, such as the abdomen and pelvis. The study highlights the advantages of proton therapy over conventional photon radiotherapy, demonstrating fewer side effects and better protection for critical organs. It was published recently in the journal Pediatric Blood and Cancer.

Jump back to top